Demographics (1)
- SEX - Sex of Participant (phv00318385.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case - control status of the subject for Non-Small Cell Lung Cancer (phv00318380.v1.p1)
Race and Ethnicity (2)
- ETHNICITY - Ethnicity of Participant (phv00318387.v1.p1)
- RACE - Race of Participant (phv00318386.v1.p1)
Substance Use (2)
- SMOKING_PACK_YEARS - Smoking History in Pack per Years (phv00318389.v1.p1)
- SMOKING_STATUS - Smoking Status of Participant (phv00318388.v1.p1)
Other (18)
- ANALYTE_TYPE - Analyte Type of Sample (phv00318396.v1.p1)
- BODY_SITE - Body Site Where Sample was Collected (phv00318400.v1.p1)
- COHORT - Subject Cohort (phv00318392.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00318379.v1.p1)
- HISTOLOGICAL_TYPE - Tissue Type or Subtype of Sample (phv00318397.v1.p1)
- ICI_TREATMENT - Immune Checkpoint Inhibitor Therapy Received by Participant (phv00318393.v1.p1)
- INTERVENING_THERAPY - Subject Received Intervening Systemic Therapy Between Collection of Pre-Treatment and ICI-Resistant Samples (phv00318394.v1.p1)
- IS_TUMOR - Tumor Status of Sample (phv00318398.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00318395.v1.p1)
- SAMPLE_ID - Sample ID (phv00318382.v1.p1)
- SAMPLE_USE - Sample Use (phv00318383.v1.p1)
- SEQUENCING_CENTER - Name of the Center Which Conducted Sequencing (phv00318401.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00318384.v1.p1)
- SUBJECT_ID - Subject ID (phv00318378.v1.p1)
- SUBJECT_ID - Subject ID (phv00318381.v1.p1)
- TUMOR_COLLECTION_TIMEPOINT - Treatment Timepoint at which Sample was Collected (phv00318399.v1.p1)
- TUMOR_HISTOLOGY - Histology of Tumor (phv00318390.v1.p1)
- TUMOR_ONCOGENIC_DRIVER - Oncogenic Driver Alteration Present in Tumor (Entrez Gene IDs: <a href="https://www.ncbi.nlm.nih.gov/gene/?term=207">207</a>, <a href="https://www.ncbi.nlm.nih.gov/gene/?term=1956">1956</a>, <a href="https://www.ncbi.nlm.nih.gov/gene/?term=2064">2064</a>, <a href="https://www.ncbi.nlm.nih.gov/gene/?term=4233">4233</a>) (phv00318391.v1.p1)